A citation-based method for searching scientific literature

Janna-Lisa Velthaus, Peter Iglauer, Ronald Simon, Carsten Bokemeyer, Peter Bannas, Niklas Beumer, Charles D Imbusch, Eray Goekkurt, Sonja Loges. Oncol Res Treat 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.
Sari Suomela, Outi Elomaa, Tiina Skoog, Risto Ala-aho, Leila Jeskanen, Jenita Pärssinen, Leena Latonen, Reidar Grénman, Juha Kere, Veli-Matti Kähäri,[...]. PLoS One 2009
27
100

AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve.
Ekrem Emrah Er, Michelle C Mendoza, Ashley M Mackey, Lucia E Rameh, John Blenis. Sci Signal 2013
71
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.
Kurtis D Davies, Sakshi Mahale, David P Astling, Dara L Aisner, Anh T Le, Trista K Hinz, Aria Vaishnavi, Paul A Bunn, Lynn E Heasley, Aik-Choon Tan,[...]. PLoS One 2013
85
100

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
Olivia Leblanc, Sophie Vacher, Charlotte Lecerf, Emmanuelle Jeannot, Jerzy Klijanienko, Frédérique Berger, Caroline Hoffmann, Valentin Calugaru, Nathalie Badois, Anne Chilles,[...]. Cancer Biol Med 2020
12
100

EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis.
C-H Shih, Y-J Chang, W-C Huang, T-H Jang, H-J Kung, W-C Wang, M-H Yang, M-C Lin, S-F Huang, S-W Chou,[...]. Oncogene 2017
27
100

A novel human leiomyoma tissue derived matrix for cell culture studies.
Tuula Salo, Meeri Sutinen, Ehsanul Hoque Apu, Elias Sundquist, Nilva K Cervigne, Carine Ervolino de Oliveira, Saad Ullah Akram, Steffen Ohlmeier, Fumi Suomi, Lauri Eklund,[...]. BMC Cancer 2015
49
100

NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data.
Daryl Waggott, Kenneth Chu, Shaoming Yin, Bradly G Wouters, Fei-Fei Liu, Paul C Boutros. Bioinformatics 2012
170
100

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
Damian Szklarczyk, Annika L Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T Doncheva, John H Morris, Peer Bork,[...]. Nucleic Acids Res 2019
100

Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
Ana Carolina de Carvalho, Sandra Perdomo, Wellington Dos Santos, Gabriela Carvalho Fernandes, Lais Machado de Jesus, Raiany Santos Carvalho, Cristovam Scapulatempo-Neto, Gisele Caravina de Almeida, Bruna Pereira Sorroche, Lidia Maria Rebolho Batista Arantes,[...]. Sci Rep 2020
5
100


RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
Sophie Doublier, Chiara Riganti, Claudia Voena, Costanzo Costamagna, Elisabetta Aldieri, Gianpiero Pescarmona, Dario Ghigo, Amalia Bosia. Mol Cancer Res 2008
42
100


Complex heatmaps reveal patterns and correlations in multidimensional genomic data.
Zuguang Gu, Roland Eils, Matthias Schlesner. Bioinformatics 2016
100

MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.
Arcadi Cipponi, David L Goode, Justin Bedo, Mark J McCabe, Marina Pajic, David R Croucher, Alvaro Gonzalez Rajal, Simon R Junankar, Darren N Saunders, Pavel Lobachevsky,[...]. Science 2020
37
100

The role of CD44 in epithelial-mesenchymal transition and cancer development.
Hanxiao Xu, Yijun Tian, Xun Yuan, Hua Wu, Qian Liu, Richard G Pestell, Kongming Wu. Onco Targets Ther 2015
134
100

The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.
Ranee Mehra, Roger B Cohen, Barbara A Burtness. Clin Adv Hematol Oncol 2008
53
100

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.
Kenichi Suda, Isao Murakami, Hui Yu, Jihye Kim, Aik-Choon Tan, Hiroshi Mizuuchi, Leslie Rozeboom, Kim Ellison, Christopher J Rivard, Tetsuya Mitsudomi,[...]. Mol Cancer Ther 2018
26
100

Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Marta Prieto-Vila, Ryou-U Takahashi, Wataru Usuba, Isaku Kohama, Takahiro Ochiya. Int J Mol Sci 2017
271
100

The growing role of precision and personalized medicine for cancer treatment.
Paulina Krzyszczyk, Alison Acevedo, Erika J Davidoff, Lauren M Timmins, Ileana Marrero-Berrios, Misaal Patel, Corina White, Christopher Lowe, Joseph J Sherba, Clara Hartmanshenn,[...]. Technology (Singap World Sci) 2018
118
100


Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Jan B Vermorken, Ricard Mesia, Fernando Rivera, Eva Remenar, Andrzej Kawecki, Sylvie Rottey, Jozsef Erfan, Dmytro Zabolotnyy, Heinz-Roland Kienzer, Didier Cupissol,[...]. N Engl J Med 2008
100

In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas.
Olga Martinho, Renato Silva-Oliveira, Vera Miranda-Gonçalves, Carlos Clara, José Reynaldo Almeida, André Lopes Carvalho, João Taborda Barata, Rui Manuel Reis. Transl Oncol 2013
49
100

AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors.
Renato José Silva-Oliveira, Matias Melendez, Olga Martinho, Maicon F Zanon, Luciano de Souza Viana, André Lopes Carvalho, Rui Manuel Reis. Oncotarget 2017
23
100

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Mari Iida, Toni M Brand, Megan M Starr, Evan J Huppert, Neha Luthar, Harsh Bahrar, John P Coan, Hannah E Pearson, Ravi Salgia, Deric L Wheeler. Mol Cancer 2014
48
100

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.
Melanie Straub, Enken Drecoll, Nicole Pfarr, Wilko Weichert, Rupert Langer, Alexander Hapfelmeier, Carolin Götz, Klaus-Dietrich Wolff, Andreas Kolk, Katja Specht. Oncotarget 2016
118
100

Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization.
Worapong Singchat, Ekarat Hitakomate, Budsaba Rerkarmnuaychoke, Aorarat Suntronpong, Beiyuan Fu, Winai Bodhisuwan, Surin Peyachoknagul, Fengtang Yang, Sittichai Koontongkaew, Kornsorn Srikulnath. PLoS One 2016
14
100

The changing therapeutic landscape of head and neck cancer.
John D Cramer, Barbara Burtness, Quynh Thu Le, Robert L Ferris. Nat Rev Clin Oncol 2019
241
100

RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.
Huang Ruihua, Zhang Mengyi, Zhao Chong, Qiu Meng, Ma Xin, Tang Qiulin, Bi Feng, Liu Ming. Oncotarget 2016
11
100


Clinical update on head and neck cancer: molecular biology and ongoing challenges.
Elham Alsahafi, Katheryn Begg, Ivano Amelio, Nina Raulf, Philippe Lucarelli, Thomas Sauter, Mahvash Tavassoli. Cell Death Dis 2019
195
100

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
100

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
Carolien Boeckx, Lina Blockx, Ken Op de Beeck, Ridha Limame, Guy Van Camp, Marc Peeters, Jan B Vermorken, Pol Specenier, An Wouters, Marc Baay,[...]. Am J Cancer Res 2015
20
100

Mechanisms of resistance to EGFR-targeted drugs: lung cancer.
Floriana Morgillo, Carminia Maria Della Corte, Morena Fasano, Fortunato Ciardiello. ESMO Open 2016
237
100

Mutational Profile of Driver Genes in Brazilian Melanomas.
Anna Luiza S A Vicente, Camila S Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui M Reis, Vinicius L Vazquez. J Glob Oncol 2019
5
100

The molecular landscape of head and neck cancer.
C René Leemans, Peter J F Snijders, Ruud H Brakenhoff. Nat Rev Cancer 2018
581
100

Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77].
Toni M Brand, Mari Iida, Neha Luthar, Megan M Starr, Evan J Huppert, Deric L Wheeler. Radiother Oncol 2019
4
100

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
Pat Gulhati, Kanika A Bowen, Jianyu Liu, Payton D Stevens, Piotr G Rychahou, Min Chen, Eun Y Lee, Heidi L Weiss, Kathleen L O'Connor, Tianyan Gao,[...]. Cancer Res 2011
408
100

The Ensembl Variant Effect Predictor.
William McLaren, Laurent Gil, Sarah E Hunt, Harpreet Singh Riat, Graham R S Ritchie, Anja Thormann, Paul Flicek, Fiona Cunningham. Genome Biol 2016
100

Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
Jan B Vermorken, José Trigo, Ricardo Hitt, Piotr Koralewski, Eduardo Diaz-Rubio, Frédéric Rolland, Rainald Knecht, Nadia Amellal, Armin Schueler, José Baselga. J Clin Oncol 2007
695
100

IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma.
Sha Zhu, B Marie Ward, Jun Yu, Asia N Matthew-Onabanjo, Jenny Janusis, Chung-Cheng Hsieh, Keith Tomaszewicz, Lloyd Hutchinson, Lihua Julie Zhu, Dina Kandil,[...]. JCI Insight 2018
15
100

Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.
Sergio Benavente, Shyhmin Huang, Eric A Armstrong, Alexander Chi, Kun-Tai Hsu, Deric L Wheeler, Paul M Harari. Clin Cancer Res 2009
74
100

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib.
Ines De Pauw, Filip Lardon, Jolien Van den Bossche, Hasan Baysal, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, An Wouters. Cancers (Basel) 2019
9
100

Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma.
Renato J Oliveira-Silva, Ana Carolina de Carvalho, Luciano de Souza Viana, André L Carvalho, Rui M Reis. Recent Pat Anticancer Drug Discov 2016
10
100

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
Astrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean-François Emile, Jean-François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux,[...]. Cancer Res 2006
100

Role of CD44 as a marker of cancer stem cells in head and neck cancer.
Serena Trapasso, Eugenia Allegra. Biologics 2012
36
100


Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
James A Bonner, Paul M Harari, Jordi Giralt, Nozar Azarnia, Dong M Shin, Roger B Cohen, Christopher U Jones, Ranjan Sur, David Raben, Jacek Jassem,[...]. N Engl J Med 2006
100

Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.
Marcela Nunes Rosa, Adriane Feijó Evangelista, Letícia Ferro Leal, Cristina Mendes De Oliveira, Viviane Aline Oliveira Silva, Carla Carolina Munari, Fernanda Franco Munari, Graziela De Macêdo Matsushita, Ricardo Dos Reis, Carlos Eduardo Andrade,[...]. Sci Rep 2019
9
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.